Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer

NCT01959490 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
BIOLOGICAL: Pertuzumab
DRUG: docetaxel
DRUG: carboplatin
DRUG: doxorubicin
DRUG: cyclophosphamide
DRUG: paclitaxel
DRUG: Bevacizumab

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]